1. Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008; 103:776–787. PMID:
18076735.
Article
2. Okuda Y, Takasugi K, Oyama T, Onuma M, Oyama H. Amyloidosis in rheumatoid arthritis--clinical study of 124 histologically proven cases. Ryumachi. 1994; 34:939–946. PMID:
7863383.
3. Menke DM, Kyle RA, Fleming CR, Wolfe JT 3rd, Kurtin PJ, Oldenburg WA. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc. 1993; 68:763–767. PMID:
8331978.
4. Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990; 36:10–14. PMID:
2311879.
5. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore). 2003; 82:291–298. PMID:
14530778.
6. Tada S, Iida M, Yao T, Kawakubo K, Okada M, Fujishima M. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc. 1994; 40:45–50. PMID:
8163134.
7. Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol. 1989; 7:407–410. PMID:
2591113.
8. Grape T, Johansson GW, Eriksson M, Toth E, Thorlacius H. Primary gastroduodenal amyloidosis. Endoscopy. 2011; 43:E288. PMID:
21915830.
Article
9. Sawada T, Adachi Y, Akino K, et al. Endoscopic features of primary amyloidosis of the stomach. Endoscopy. 2012; 44(Suppl 2):E275–E276. PMID:
22814919.
Article
10. Kim SH, Han JK, Lee KH, et al. Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol. 2003; 58:610–620. PMID:
12887954.
Article
11. Araoz PA, Batts KP, MacCarty RL. Amyloidosis of the alimentary canal: radiologic-pathologic correlation of CT findings. Abdom Imaging. 2000; 25:38–44. PMID:
10652919.
Article
12. Mekinian A, Jaccard A, Soussan M, et al. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid. 2012; 19:94–98. PMID:
22587492.
Article
13. Glaudemans AW, Slart RH, Noordzij W, Dierckx RA, Hazenberg BP. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis. Eur J Nucl Med Mol Imaging. 2013; 40:1095–1101. PMID:
23474745.
Article
14. Tang YH, Wu YW, Zong J, Wang JC, Miao F. Imaging features of small intestinal amyloidosis: a case report. Abdom Imaging. 2011; 36:694–697. PMID:
21221573.
Article
15. Mainenti PP, Segreto S, Mancini M, et al. Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation. World J Gastroenterol. 2010; 16:2566–2570. PMID:
20503459.
Article
16. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009; 23:3–9. PMID:
18971951.
Article
17. Rajkumar SV. Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011; 86:57–65. PMID:
21181954.
Article
18. Hamidi Asl K, Liepnieks JJ, Nakamura M, Benson MD. Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol. 1999; 162:5556–5560. PMID:
10228037.
Article